Morgan Stanley raised the firm’s price target on Procter & Gamble to $174 from $160 and keeps an Overweight rating on the shares. The shares were up 3.5% following what the firm describes as "a strong, high quality Q3 EPS result," but the firm continues to like the stock given what it sees as higher visibility around above-consensus organic sales growth and a gross margin recovery.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PG:
- P&G Stock (NYSE:PG): Why I’m Not Buying Despite Strong Q3 Earnings
- Procter & Gamble price target raised to $175 from $170 at Raymond James
- P&G issues retrieval of limited number of Zevo insect killer value packs
- Procter & Gamble sees runway on productivity growth over next few years
- Procter & Gamble says organic sales grew across all categories in Q3